Effect of Tezepelumab on Sino-Nasal Outcome Test (SNOT)-22 Domain and Symptom-Specific Scores in Patients with Severe, Uncontrolled Asthma and a History of Chronic Rhinosinusitis with Nasal Polyps
Effect of Tezepelumab on Sino-Nasal Outcome Test (SNOT)-22 Domain and Symptom-Specific Scores in Patients with Severe, Uncontrolled Asthma and a History of Chronic Rhinosinusitis with Nasal Polyps
Joshua Jacobs, Flavia Hoyte, Tanya M. Laidlaw, Scott Caveney et al.
Citations
14 citations
Journal
Advances in Therapy
Topics
Allergic Rhinitis and Sensitization
Field-Weighted Citation Impact (FWCI)
5.36
article
Effect of Tezepelumab on Sino-Nasal Outcome Test (SNOT)-22 Domain and Symptom-Specific Scores in Patients with Severe, Uncontrolled Asthma and a History of Chronic Rhinosinusitis with Nasal Polyps
Joshua Jacobs, Flavia Hoyte, Tanya M. Laidlaw, Scott Caveney, Joseph D. Spahn, Christopher S. Ambrose, Jason K. Lee, Nicole L. Martin, Neil Martin, Joseph K. Han
article en
14 citations
Abstract
No abstract available for this paper.
Publication Tag
Advances in TherapyVol. 42(1)
Institutions
AstraZeneca (United Kingdom) (GB), Brigham and Women's Hospital (US), Center for Global Development (US), Amgen (United States) (US), Harvard University (US), University of Leicester (GB), Eastern Virginia Medical School (US), National Jewish Health (US), Allergy, Asthma and Clinical Research Center (US), AstraZeneca (United States) (US), NIHR Leicester Biomedical Research Centre (GB), University of Colorado Denver (US), Cytel (United States) (US)